Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of 5' NAD capped viral RNAs reveals evolutionary divergent 5' metabolite capping across hepaciviruses.

Nature communications·2026
Same author

The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study.

Clinical epidemiology·2026
Same author

Hepatitis C virus infection dynamics, treatment, and lipid nanoparticle-mediated infection in humanized liver chimeric mouse models.

Science advances·2026
Same author

Development of a Norway rat hepacivirus reporter for high-throughput quantification of neutralizing antibodies.

Journal of virology·2026
Same author

A general one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging.

Nature communications·2026
Same author

In Vivo Determinants of Hepatitis C Virus Adaptation and Escape From Neutralizing Antibody AR5A.

Cellular and molecular gastroenterology and hepatology·2025

Related Experiment Video

Updated: Jun 27, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Mapping Determinants of Hepatitis C Virus E1/E2 Transmembrane Interactions Using Intergenotypic Chimeras.

Margherita Fanalista1,2, Christina Holmboe Olesen1,2, Rodrigo Velázquez-Moctezuma1,2,3

  • 1Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, 2650 Hvidovre, Denmark.

Viruses
|June 26, 2026
PubMed
Summary

Investigating Hepatitis C virus (HCV) transmembrane regions revealed their critical role in viral infectivity. Adaptive mutations in E1/E2 regions are key for recovery, informing future HCV vaccine development.

Keywords:
E1/E2 glycoproteinsHCVglycoprotein assemblymembrane interactionstransmembrane domainsviral entry

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jun 27, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge with no available preventive vaccine.
  • The E1/E2 envelope glycoproteins complex is crucial for viral entry, but its assembly and stability mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the role of E1/E2 transmembrane (TM) regions in HCV infectivity.
  • To explore the impact of swapping TM domains between different HCV genotypes on viral function.

Main Methods:

  • Constructed chimeric HCV recombinants by swapping C-terminal TM domains (TME1, TME2, TME1E2) of E1/E2 glycoproteins between different genotypes (H77, S52, J6).
  • Assessed infectivity of TM-swap chimeras and analyzed adaptive mutations following serial passaging.
  • Investigated the effect of extending TME1 swaps and including internal E1 TM regions (iTME1).

Main Results:

  • Most TM-swap chimeras exhibited reduced infectivity.
  • Serial passaging led to partial infectivity recovery through adaptive mutations in E1/E2, including TM, stem, and iTME1 regions.
  • Extending TME1 swaps improved infectivity in some cases, while iTME1 inclusion abolished it.

Conclusions:

  • HCV E1/E2 transmembrane regions and associated membrane-proximal domains significantly influence viral infectivity.
  • Functional interactions exist between membrane-associated regions and ectodomains of E1/E2.
  • Findings are relevant for developing E1/E2-based HCV vaccines.